Cleveland Clinic Cole Eye Institute Receives $3 Million Endowed Chair
Cole Eye Institute Chairman Daniel F. Martin, MD, Appointed The Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology
September 28, 2011
Cleveland Clinic’s Cole Eye Institute received a $3 million gift from Barbara and A. Malachi Mixon III in recognition of the sight-saving care Mr. Mixon received at the Institute.
The gift establishes the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology. Daniel F. Martin, MD, Chairman of Cole Eye Institute, is being honored as the first physician to hold the newly established chair. As chair holder, Dr. Martin will continue his research initiatives to better understand eye diseases and to pioneer new treatments.
“We are grateful for the generosity of the Mixon family,” Dr. Martin said. “This gift will provide resources to advance our research efforts, including increasing involvement in clinical trials and serving as a catalyst for cutting-edge research programs.”
Mr. Mixon served as Chairman of Cleveland Clinic’s Board of Directors from 2003 to 2010. He was elected to the Cleveland Clinic Board of Trustees in 1990 and named its Chair in 1997. He was elected to the Board of Directors in 1992. In December 2010, he was elected as Chair Emeritus of the Board of Directors and Board of Trustees.
“My wife and I are honored to support the Cole Eye Institute and Dr. Martin with the establishment of the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology,” Mr. Mixon said. “Dr. Martin is an accomplished physician who helped save my vision and I am grateful for the wonderful care I’ve received.”
Mr. Mixon leads the Cole Eye Institute’s Leadership Board, assisting with development efforts to continue to elevate Cole among the top eye centers in the nation.
Dr. Martin is an established leader in the development of new therapies for retinal disease. He has been involved in the design and development of many clinical trials, having served as principal investigator for a number of seminal studies of age-related macular degeneration, diabetes, uveitis and CMV retinitis. Dr. Martin served as Study Chair for the trials that led to FDA approval of the ganciclovir implant and for the trials that lead to FDA approval of valganciclovir.
Dr. Martin currently serves as the Study Chair for the Comparison of AMD Treatments Trials (CATT), an NIH-sponsored study evaluating the comparative efficacy and safety of Lucentis and Avastin for the treatment of neovascular AMD. The one-year results from this groundbreaking study were recently published in the New England Journal of Medicine.
Dr. Martin received his medical degree from The Johns Hopkins University School of Medicine, completed his ophthalmology residency at Emory followed by fellowships at Duke University Medical Center and the National Eye Institute at the National Institutes of Health.
Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll.
About Cleveland Clinic
Celebrating its 90th anniversary, Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. It was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. About 2,800 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. Cleveland Clinic Health System includes a main campus near downtown Cleveland, nine community hospitals and 15 Family Health Centers in Northeast Ohio, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and opening in 2013, Cleveland Clinic Abu Dhabi. In 2010, there were 4 million visits throughout the Cleveland Clinic health system and 155,000 hospital admissions. Patients came for treatment from every state and from more than 100 countries. Visit us at www.clevelandclinic.org. Follow us at www.twitter.com/ClevelandClinic.
Maureen Nagg, 216.444.5703, email@example.com